Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Ogden Christopher
Chief Financial Officer at CytomX Therapeutics. Filing since 16 Mar 2023.
CIK 0001914523
Company
Date
Role
Action
Shares
Amount
Of holding
CTMX
CytomX Therapeutics, Inc.
15 Jun 2026
Chief Financial Officer
Sold at will
1,624
$4.95K
0.5%
CTMX
CytomX Therapeutics, Inc.
17 Mar 2026
Chief Financial Officer
Sold at will
19,323
$124.11K
6.1%
CTMX
CytomX Therapeutics, Inc.
16 Jun 2025
Chief Financial Officer
Sold at will
10,614
$28.54K
4.5%
CTMX
CytomX Therapeutics, Inc.
13 Jun 2025
Chief Financial Officer
Sold at will
1,641
$4.84K
0.8%
CTMX
CytomX Therapeutics, Inc.
18 Mar 2025
Chief Financial Officer
Sold at will
8,551
$5.12K
4.1%
CTMX
CytomX Therapeutics, Inc.
20 Aug 2024
Chief Financial Officer
Sold at will
1,984
$2.44K
1.8%
CTMX
CytomX Therapeutics, Inc.
19 Mar 2024
SVP, Finance and Accounting
Sold at will
2,971
$6.20K
3.4%
CTMX
CytomX Therapeutics, Inc.
20 Dec 2023
SVP, Finance and Accounting
Sold at will
1,990
$2.75K
3.9%
CTMX
CytomX Therapeutics, Inc.
16 Mar 2023
SVP, Finance and Accounting
Sold at will
516
$1.02K
1.3%
9 decisions on file.
